Moderna expects approval of 2nd RSV shot in 1st half of 2024

Moderna anticipates initial regulatory approvals for its RSV vaccine in first half of 2024.

Related Keywords

, Advisory Committee On Immunization Practices , License Application , Immunization Practices , Giant , Nitial , Approvals , Espiratory , Earnings , Update , Moderna , Egulatory , Harmaceutical , Virus ,